中国儿童保健杂志 ›› 2024, Vol. 32 ›› Issue (3): 296-300.DOI: 10.11852/zgetbjzz2023-0489

• 综述 • 上一篇    下一篇

药物遗传学对注意缺陷多动障碍儿童盐酸哌甲酯治疗的影响

任苗苗, 陈立   

  1. 重庆医科大学附属儿童医院儿童保健科(健康管理部) / 国家儿童健康与疾病临床医学研究中心/儿童发育疾病研究教育部重点实验室/ 儿童发育重大疾病国家国际科技合作基地/儿童营养与健康重庆市重点实验室,重庆 400014
  • 收稿日期:2023-05-17 修回日期:2023-09-28 发布日期:2024-03-04 出版日期:2024-03-10
  • 通讯作者: 陈立,E-mail:chenli@cqmu.edu.cn
  • 作者简介:任苗苗(1996-),住院医师,在读硕士研究生,主要研究方向为儿童发育障碍性疾病。
  • 基金资助:
    重庆市科卫联合医学科研项目重点项目(2018ZDXM012)

Pharmacogenetic impact on the methylphenidate-hydrocloride treatment in children with attention-deficit hyperactivity disorder

REN Miaomiao, CHEN Li   

  1. Child Healthcare Department (Health Management Department), Children's Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Child Nutrition and Health, Chongqing 400014
  • Received:2023-05-17 Revised:2023-09-28 Online:2024-03-10 Published:2024-03-04
  • Contact: CHEN Li,E-mail:chenli@cqmu.edu.cn

摘要: 注意缺陷多动障碍(ADHD)是儿童期最常见的慢性神经发育障碍之一,以与发育水平不匹配的注意力不集中、多动冲动为主要表现,可能导致多种功能损害,给个人、家庭、社会带来沉重负担。盐酸哌甲酯(MPH)是一种ADHD一线治疗药物,临床应用广泛,但部分患者对药物治疗无反应、出现不良反应等原因过早终止治疗。在治疗中引入药物遗传学的概念可能为 ADHD的个体化干预开辟新的途径。本文旨在综述药物遗传学对ADHD儿童MPH治疗的影响,为临床药物治疗及管理提供参考。

关键词: 注意缺陷多动障碍, 药物遗传学, 盐酸哌甲酯, 药代动力学, 药效动力学

Abstract: Attention-deficit hyperactivity disorder (ADHD) is one of the most common chronic neurodevelopmental disorders in childhood.It is mainly manifested as inattention, hyperactivity, and impulsivity that are inconsistent with the development level, which may lead to multiple functional impairments and place heavy burdens on individuals, families, and society.Methylphenidate hydrochloride (MPH) is a first-line treatment drug for ADHD, which is widely used in clinical practice.However, some patients have no response to drug treatment and adverse reactions often cause premature termination of treatment.Introducing the concept of pharmacogenetics into MPH treatment may open new avenues for individualized interventions of ADHD.This paper aims to review the impact of pharmacogenetics on MPH treatment in children with ADHD and to provide references for clinical drug treatment and management.

Key words: attention-deficit hyperactivity disorder, pharmacogenetics, methylphenidate-hydrocloride, pharmacokinetics, pharmacodynamics

中图分类号: